| Dec'17 | Dec'16 | Dec'15 | Dec'14 | |||
|---|---|---|---|---|---|---|
Revenues | ||||||
Sales-third parties | ||||||
196,720 | 171,058 | 118,113 | 59,162 | |||
Sales-related parties | ||||||
8,486 | 9,794 | 8,074 | 7,823 | |||
Revenue from license and collaboration agreements-third parties | ||||||
26,315 | 26,444 | 44,060 | 12,336 | |||
Revenue from research and development services-third parties | ||||||
- | 355 | 2,573 | 3,696 | |||
Revenue from research and development services-related parties | ||||||
9,682 | 8,429 | 5,383 | 4,312 | |||
Total revenues | ||||||
241,203 | 216,080 | 178,203 | 87,329 | |||
Operating expenses | ||||||
Costs of sales-third parties | ||||||
169,764 | 149,132 | 104,859 | 53,477 | |||
Costs of sales-related parties | ||||||
6,056 | 7,196 | 5,918 | 5,372 | |||
Research and development expenses | ||||||
75,523 | 66,871 | 47,368 | 29,914 | |||
Selling expenses | ||||||
19,322 | 17,998 | 10,209 | 4,112 | |||
Administrative expenses | ||||||
23,955 | 21,580 | 19,620 | 12,713 | |||
Total operating expenses | ||||||
294,620 | 262,777 | 187,974 | 105,588 | |||
Loss from operations | ||||||
-53,417 | -46,697 | -9,771 | -18,259 | |||
Interest income | ||||||
1,220 | 502 | 451 | 559 | |||
Other income | ||||||
808 | 609 | 386 | 20 | |||
Interest expense | ||||||
1,455 | 1,631 | 1,404 | 1,516 | |||
Other expense | ||||||
692 | 139 | 202 | -761 | |||
Other income/(expense) | ||||||
-119 | -659 | -769 | -1,698 | |||
Loss before income taxes and equity in earnings of equity investees | ||||||
-53,536 | -47,356 | -10,540 | -19,957 | |||
Income tax expense | ||||||
3,080 | 4,331 | 1,605 | 1,343 | |||
Equity in earnings of equity investees, net of tax | ||||||
33,653 | 66,244 | 22,572 | 15,180 | |||
Net income/(loss) from continuing operations | ||||||
- | - | - | -6,120 | |||
Income from discontinued operation, net of tax | ||||||
- | - | - | 2,034 | |||
Net (loss)/income | ||||||
-22,963 | 14,557 | 10,427 | -4,086 | |||
Less: Net income attributable to non-controlling interests | ||||||
3,774 | 2,859 | 2,434 | 3,220 | |||
Net (loss)/income attributable to the Company | ||||||
-26,737 | 11,698 | 7,993 | -7,306 | |||
Accretion on redeemable non-controlling interests | ||||||
- | - | 43,001 | -25,510 | |||
Net (loss)/income attributable to ordinary shareholders of the Company | ||||||
-26,737 | 11,698 | -35,008 | -32,816 | |||
(Losses)/earnings per share attributable to the Company-basic (US$ per share) | ||||||
-0.43 | 0.20 | -0.64 | - | |||
(Losses)/earnings per share attributable to the Company-diluted (US$ per share) | ||||||
-0.43 | 0.20 | -0.64 | - | |||
Continuing operations | ||||||
- | - | - | -0.64 | |||
Discontinued operation | ||||||
- | - | - | 0.02 | |||
Continuing operations | ||||||
- | - | - | -0.64 | |||
Discontinued operation | ||||||
- | - | - | 0.02 | |||
Number of shares used in per share calculation-basic | ||||||
61,717 | 59,715 | 54,659 | 52,563 | |||
Number of shares used in per share calculation-diluted | ||||||
61,717 | 59,971 | 54,659 | 52,563 | |||